Rhelion Life Sciences Corp (RHEL.CN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 03/31
| 09-2023 | 06-2023 | 03-2023 | 12-2022 | 09-2022 | |
| Sales | 983 | 1,202 | 1,253 | 1,175 | 736 |
| Cost of Goods | 539 | 679 | 710 | 588 | 449 |
| Gross Profit | 445 | 523 | 543 | 587 | 288 |
| Operating Expenses | 1,621 | 2,497 | 1,746 | 1,698 | 1,527 |
| Operating Income | -1,176 | -1,974 | -1,203 | -1,111 | -1,239 |
| Interest Expense | 60 | 46 | 37 | 9 | 6 |
| Other Income | 109 | 133 | -419 | -254 | -93 |
| Pre-tax Income | -1,127 | -1,888 | -1,659 | -1,374 | -1,338 |
| Income Tax | -19 | -11 | -11 | -61 | -33 |
| Net Income Continuous | -1,108 | -1,877 | -1,648 | -1,312 | -1,305 |
| Minority Interests | 41 | 1 | 322 | 7 | 41 |
| Net Income | $-1,067 | $-1,876 | $-1,325 | $-1,305 | $-1,264 |
| EBITDA(a) | $-897 | $-1,672 | $-1,435 | $-1,209 | $-1,188 |